|
103050: Proton pump inhibitors
|
4643
|
228
|
1.84 (1.51, 2.23)
|
7×10−10
|
|
104020: Antimotility drugs
|
262
|
20
|
2.84 (1.60, 5.05)
|
4×10−4
|
|
105010: Aminosalicylates
|
148
|
15
|
3.55 (1.83, 6.89)
|
2×10−4
|
|
106040: Osmotic laxatives
|
1251
|
78
|
2.33 (1.71, 3.18)
|
1×10−7
|
|
401020: Anxiolytics
|
485
|
41
|
2.17 (1.46, 3.23)
|
1×10−4
|
|
402010: Antipsychotic drugs
|
165
|
25
|
3.89 (2.29, 6.62)
|
5×10−7
|
|
403010: Tricyclic and related antidepressant drugs
|
1037
|
64
|
1.86 (1.36, 2.54)
|
9×10−5
|
|
403040: Other antidepressant drugs
|
498
|
48
|
2.74 (1.89, 3.97)
|
1×10−7
|
|
407010: Non-opioid analgesics and compound preparations
|
4202
|
223
|
2.05 (1.68, 2.50)
|
1×10−12
|
|
407020: Opioid analgesics
|
1028
|
79
|
2.32 (1.72, 3.13)
|
3×10−8
|
|
408010: Control of epilepsy
|
746
|
51
|
2.31 (1.63, 3.28)
|
3×10−6
|
|
501012: Penicillinase-resistant penicillins
|
571
|
41
|
2.28 (1.53, 3.39)
|
5×10−5
|
|
501013: Broad-spectrum penicillins
|
1155
|
69
|
1.92 (1.42, 2.62)
|
3×10−5
|
|
603020: Use of corticosteroids
|
333
|
33
|
3.36 (2.11, 5.35)
|
3×10−7
|
|
901011: Oral iron
|
409
|
26
|
2.81 (1.66, 4.78)
|
1×10−4
|
|
901020: Drugs used in megaloblastic anaemias
|
1018
|
56
|
2.14 (1.51, 3.04)
|
2×10−5
|
|
904020: Enteral nutrition
|
99
|
17
|
5.8 (2.7, 12.2)
|
5×10−6
|
|
906026: Thiamine hydrochloride (B1)
|
122
|
15
|
3.11 (1.59, 6.07)
|
9×10−4
|
|
906040: Vitamin D
|
1730
|
73
|
1.85 (1.33, 2.58)
|
3×10−4
|
|
1001010: Non-steroidal anti-inflammatory drugs
|
1438
|
86
|
1.71 (1.31, 2.22)
|
7×10−5
|
|
1003020: Rubefacients, topical NSAIDS, capsaicin and poultice
|
1780
|
80
|
1.61 (1.21, 2.14)
|
1×10−3
|
